Physician profile
Nancy Aria
NPI 1730280231
$1,208.50
in general payments reported to CMS, 2019-2025
23 companies · $71.08 in 2025
The $71.08 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2020: $108 · 2021: $12.69 · 2022: $149 · 2023: $171 · 2024: $212 · 2025: $71.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $127.12 | 2019-2022 | |
| Pfizer INC. | $122.07 | 2019-2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $98.80 | 2019-2023 | Arazlo, Jublia |
| Almirall LLC | $98.46 | 2019-2022 | |
| Arcutis Biotherapeutics, INC. | $89.22 | 2023-2024 | Zoryve |
| Mayne Pharma Commercial LLC | $82.78 | 2019-2022 | |
| Incyte Corporation | $67.77 | 2022-2024 | Opzelura |
| Dermavant Sciences, INC. | $63.54 | 2022-2024 | Vtama |
| Galderma Laboratories, L.P. | $59.05 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $51.98 | 2023-2025 | Libtayo, Dupixent |
| Organon LLC | $50.74 | 2025 | Vtama |
| Encore Dermatology INC. | $46.48 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $45.74 | 2019-2023 | Winlevi, Absorica Ld |
| Leo Pharma INC. | $42.53 | 2019 | |
| Merz North America, INC. | $28.38 | 2019-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $25.56 | 2024 | Sotyktu |
| Helsinn Therapeutics (U.S.), INC. | $17.96 | 2019 | |
| Epi Health, LLC | $16.24 | 2020 | |
| Celgene Corporation | $15.49 | 2019 | |
| Sandoz INC. | $15.43 | 2020 | |
| Dermira, INC. | $14.74 | 2020 | |
| Promius Pharma LLC | $14.60 | 2019 | |
| Sebela Pharmaceuticals INC. | $13.82 | 2023 | Naftin, Pramosone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Aria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.